Takeda Pharmaceutical Total Liabilities and Share Holders Equity 2010-2024 | TAK

Takeda Pharmaceutical total liabilities and share holders equity for the quarter ending June 30, 2024 was $103.857B, a 3.82% decline year-over-year.

  • Takeda Pharmaceutical total liabilities and share holders equity for 2024 was $104.251B, a 0.93% increase from 2023.
  • Takeda Pharmaceutical total liabilities and share holders equity for 2023 was $103.287B, a 11.93% decline from 2022.
  • Takeda Pharmaceutical total liabilities and share holders equity for 2022 was $117.284B, a 3.37% decline from 2021.

Takeda Pharmaceutical Total Liabilities and Share Holders Equity 2010-2024 | TAK

  • Takeda Pharmaceutical total liabilities and share holders equity for 2024 was $104.251B, a 0.93% increase from 2023.
  • Takeda Pharmaceutical total liabilities and share holders equity for 2023 was $103.287B, a 11.93% decline from 2022.
  • Takeda Pharmaceutical total liabilities and share holders equity for 2022 was $117.284B, a 3.37% decline from 2021.